LCN2 and colitis: Relevant to this is the fact that in PBS-dosed ADR-159 fed animals we did not detect altered levels of LCN2, which is a proxy for (sub-)colitis inflammation (Chassaing et al., 2012); indicating that we did not observe a pro-inflammatory effect in PBS-dosed ADR-159 fed animals.